The creation of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, involves a complex several-stage synthetic process. Early routes focused on peptide fragment coupling, utilizing solid-phase https://rafaelqiuc125588.livebloggs.com/47454398/production-and-investigation-implementations-of-retatrutide